A Platform Study for solId orgaN CancERs

Launched by UNIVERSITY OF LIVERPOOL · Dec 6, 2022

Keywords

ClinConnect Summary

This clinical trial, called "A Platform Study for Solid Organ Cancers," is focused on improving the way we collect and study tumor samples from cancer patients. Researchers want to create a more efficient system to gather tissue samples, which are important for understanding the biology of different cancers. By using both fresh samples from surgeries and older samples that have been preserved, they hope to build a rich database that can help in the development of new treatments and therapies.

If you are an adult aged 18 to 80 and have undergone a biopsy or surgery for cancer, you might be eligible to participate. The study is currently recruiting participants and aims to gather as much valuable information as possible while respecting your privacy. If you choose to take part, you will help researchers gain insights that could lead to better cancer care in the future. It's important to note that children cannot participate, and individuals who cannot or do not want to give consent will be excluded.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Biopsy or surgical resection as standard of care
• Exclusion Criteria:
• • Refusal or inability to consent, paediatric patients